Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial-Reference-Cited by-同舟云学术

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial

Published:2021-10 Issue:10308 Volume:398 Page:1305-1316
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kim Chan Joon,Park Mahn-Won,Kim Min Chul,Choo Eun-Ho,Hwang Byung-Hee,Lee Kwan Yong,Choi Yun Seok,Kim Hee-Yeol,Yoo Ki-Dong,Jeon Doo-Soo,Shin Eun-Seok,Jeong Young-Hoon,Seung Ki-Bae,Jeong Myung Ho,Yim Hyeon Woo,Ahn Youngkeun,Chang Kiyuk,Kim Chan Joon,Park Mahn-Won,Kim Min Chul,Choo Eun-Ho,Hwang Byung-Hee,Lee Kwan Yong,Choi Yun Seok,Kim Hee-Yeol,Yoo Ki-Dong,Jeon Doo-Soo,Shin Eun-Seok,Jeong Yong-Hoon,Seung Ki-Bae,Jeon Myung Ho,Ahn Youngkeun,Chang Kiyuk,Oh Ju-Hyeon,Ha Sang Jin,Baek Ju Yeol,Jung Kyung Tae,Doh Joon-Hyung,Kim Won,Kim Dong-Bin,Cha Kwang Soo,Yoon Myeong-Ho,Hur Seung-Ho,Lee Seung-Hwan,Cho Byung-Ryul,Park Jong-Seon,Koh Jin Shin,Kim Sang-Hyun,Cho Jang Hyun,Shim Byung Joo,Kim Sang Wook,Jang Jae-Sik,Kim Kee-Sik,Shin Won-Yong,Sung Ki-Chul

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;Collet;Eur Heart J,2021

2. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

3. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

4. Effect of the Novel Thienopyridine Prasugrel Compared With Clopidogrel on Spontaneous and Procedural Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

5. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention;Velders;Heart,2016

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Therapy in Acute Coronary Syndrome;Interventional Cardiology Clinics;2024-10

2. Genotype-Guided De-Escalation of DAPT;JACC: Cardiovascular Interventions;2024-09

3. Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients;JACC: Cardiovascular Interventions;2024-09

4. Precision Medicine in Acute Coronary Syndromes;Journal of Clinical Medicine;2024-08-05

5. Chez les patients présentant un syndrome coronarien aigu et ayant subi une intervention coronarienne percutanée avec des endoprothèses contemporaines et qui n’ont pas eu d’événement ischémique ou hémorragique pendant 1 mois sous traitement antiplaquettaire double, est-ce qu’un traitement par ticagrélor seul entre le 1er et le 12e mois diminue le risque de saignement cliniquement important tout en étant efficace pour prévenir les complications vasculaires comparativement au ticagrélor combiné à l’aspirine ?;La Revue de Médecine Interne;2024-08